https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Cost-effectiveness of targeted thrombolytic therapy for stroke patients using multi-modal CT compared to usual practice https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35040 Wed 17 Nov 2021 16:32:15 AEDT ]]> Validating a predictive model of acute advanced imaging biomarkers in ischemic stroke https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33108 Wed 06 Apr 2022 14:05:06 AEST ]]> Intravenous thrombolysis may not improve clinical outcome of acute ischemic stroke patients without a baseline vessel occlusion https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36439 Thu 27 Jan 2022 15:55:31 AEDT ]]> Perfusion computed tomography in patients with stroke thrombolysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31435 P < 0.001). For every millilitre of penumbra salvaged, 7.2 days of disability-adjusted life-year days were saved (ß = -7.2, 95% confidence interval, -10.4 to -4.1 days, P < 0.001). Each minute of earlier onset-to-treatment time resulted in a saving of 4.4 disability-free days after stroke (1.3-7.5 days, P = 0.006). However, after adjustment for imaging variables, onset-to-treatment time was not significantly associated with savings in disability-adjusted life-year days. Pretreatment perfusion computed tomography can (independently of clinical variables) predict significant gains, or loss, of disability-free life in patients undergoing reperfusion therapy for stroke. The effect of earlier treatment on disability-free life appears explained by salvage of penumbra, particularly when the ischaemic core is not too large.]]> Thu 17 Feb 2022 09:30:10 AEDT ]]>